Novel Pyridazinone Derivatives

摘要

Disclosed are compounds according to the general formula (I), where the definitions of the substituents X, R¹ and R² are detailed in the description, as well as their physiologically acceptable salts and solvate, methods for producing these compounds and their use as pharmaceuticals. These compounds are kinase inhibitors, in particular inhibitors of the kinase CDK2 (cyclin-dependent kinase 2).